4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-17-002467
Options or other derivatives
- Director acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TRAVERSA SERGIO Director | 2017-03-14 | Grant or award · Options to purchase common stock | +75,000 | $1.39 | $104,250 | 75,000 | D |
Loading xslF345X03/f4031417traversa_actinium.xml…